Dasman Diabetes Institute
Kuwait City, Sharq, 15462, Kuwait
Location status: Recruiting
NCT Number: NCT06984133
Type 1 diabetes is becoming more common in Kuwaiti and Arab adolescents. Many young people with this condition struggle to keep their blood glucose levels under control, which can lead to diabetes-related complications and affect their quality of life.
The goal of this clinical trial is to evaluate the effectiveness of a structured educational program on glycemic control among Arab adolescents with type 1 diabetes aged 11 to 14 years.
Participants will be randomly assigned to one of two groups. The intervention group will receive the structured education program, and the control group will continue with standard care.
All participants will undergo assessments that include:
* collecting demographic and diabetes management data * measuring weight and height * measuring HbA1c levels and lipid profile * filling out questionnaires on quality of life, carbohydrate and insulin dosing knowledge, physical activity * collecting dietary intake * providing AGP report
Participants in the intervention group will additionally be required to:
* attend the program for 4 consecutive days, one day for parents and three days for children * fill out 3-day food diary records during the program * attend a refresher course after 6 months
Participants in the control group will have the opportunity to participate in the program after approximately six months.
Interested in participating?
Request Info11 year–14 year
All sexes
Interventional
Not applicable
Kuwait City, Sharq, 15462, Kuwait
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A structured group educational program culturally adapted from a UK model for adolescents with type 1 diabetes. The program aims to empower adolescents by providing knowledge and tools needed for effective diabetes management.
It is delivered by dietitians, diabetes educators, and a pediatric endocrinologist in small groups. The curriculum targets both caregivers and adolescents: the first day is for parents and covers diabetes basics, management of hypoglycemia and hyperglycemia, insulin dosing, sick day management, and exercise considerations. The following three days focus on adolescents and include interactive sessions on the role of food in diabetes management, the effect of different nutrients on blood glucose levels, carbohydrate sources, reading food labels, advanced carbohydrate counting, and insulin dose adjustment.
Time frame: Baseline and 6 months
Change in HbA1c Levels from baseline to 6 months
Time frame: Baseline and 6 months
Change in %TIR from baseline to 6 months
Time frame: Baseline and 6 months
Change in Carbohydrate Counting and Insulin Adjustment Knowledge Scores from baseline to 6 months
Time frame: Baseline and 6 months
Change in Diabetes-Specific Quality of Life Scores from baseline to 6 months, will be assessed using the validated Arabic version of the Pediatric Quality of Life Inventory 3.0 Diabetes Module (PedsQL DM).
Time frame: Baseline and 6 months
This will be assessed by:
a) the percentage of time blood glucose levels are below the target range (%TBR), and b) parent-reported episodes requiring treatment such as glucagon administration.
Time frame: Baseline and 6 months
Frequency of hospital admissions for diabetic ketoacidosis or hypoglycemia, reported by parents, within a month prior the assessment visit.
Contact information is provided by the study sponsor or research team.
Dasman Diabetes Institute
Other
Evaluating the Effectiveness of a Structured Educational Program on Glycemic Control in Adolescents With Type 1 Diabetes: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07226583
Autoimmune Diseases, Behavior
Palo Alto, California, United States
View Trial DetailsNCT07463209
Autoimmune Diseases, Diabetes (DM)
Chapel Hill, North Carolina, United States
View Trial DetailsNCT06752369
Autoimmune Diseases, Behavior
Orlando, Florida, United States
View Trial DetailsNCT07599982
Autoimmune Diseases, Diabetes Mellitus
Detroit, Michigan, United States
View Trial Details